You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 41 No. 5, May 1949 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (12)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

TREATMENT OF PEDICULOSIS CILIARIS WITH ANTICHOLINESTERASE AGENTS

Report of a Case

DAVID G. COGAN, M.D.; W. MORTON GRANT, M.D.

Arch Ophthal. 1949;41(5):627-628.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

NEW DRUGS for the treatment of pediculosis ciliaris cannot be said to be especially needed. The time-honored ammoniated mercury has proved itself effective when used liberally enough. Yet it is of considerable interest, and may be of some practical usefulness, to know that the common physostigmine in the standard concentrations used for the treatment of glaucoma is just as effective as ammoniated mercury, if not more so. Tetraethylpyrophosphate, and presumably many other anticholinesterase compounds, are also effective.

A case in which we had an opportunity to study the effect of physostigmine and tetraethylpyrophosphate is reported.

REPORT OF CASE

E. B., a woman aged 49, during routine refraction, was noted to have blepharitis. In reply to questioning, she stated she had had severe itching of the lids, especially at night. Gross examination showed black discoloration of the eyelashes and loose, tiny black dots on the cheeks below the lashes. The first . . . [Full Text PDF of this Article]


Author Affiliations

BOSTON

From the Howe Laboratory of Ophthalmology, Harvard Medical School, and the Massachusetts Eye and Ear Infirmary.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1949 American Medical Association. All Rights Reserved.